Furthermore, in ex vivo drug sensitivity profiling, Giliberto et al. used the short-term stimulation of patient-derived CD138+ MM cells in 2D cultures to evaluate synergistic drug combinations. This evidence concerns the gene SDC1 and Miyoshi myopathy.